These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22903525)

  • 21. Detection of Memory B Activity Against a Therapeutic Protein in Treatment-Naïve Subjects.
    Liao K; Derbyshire S; Wang KF; Caucci C; Tang S; Holland C; Loercher A; Gunn GR
    AAPS J; 2018 Mar; 20(3):51. PubMed ID: 29549534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the ELISA and ECL Assay for Vedolizumab Anti-drug Antibodies: Assessing the Impact on Pharmacokinetics and Safety Outcomes of the Phase 3 GEMINI Trials.
    Wyant T; Yang L; Rosario M
    AAPS J; 2020 Nov; 23(1):3. PubMed ID: 33200296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics.
    Gorovits B; Wakshull E; Pillutla R; Xu Y; Manning MS; Goyal J
    J Immunol Methods; 2014 Jun; 408():1-12. PubMed ID: 24861938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a novel immunogenicity assay to detect anti-drug and anti-PEG antibodies simultaneously with high sensitivity.
    Bivi N; Swearingen CA; Shockley TE; Sloan JH; Pottanat TG; Carter QL; Hodsdon ME; Siegel RW; Konrad RJ
    J Immunol Methods; 2020 Nov; 486():112856. PubMed ID: 32916164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of Golimumab and its Clinical Relevance in Patients With Ulcerative Colitis.
    Adedokun OJ; Gunn GR; Leu JH; Gargano C; Xu Z; Sandborn WJ; Rutgeerts P; Shankar G
    Inflamm Bowel Dis; 2019 Aug; 25(9):1532-1540. PubMed ID: 30753466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives on exploring hybrid LBA/LC-MS approach for clinical immunogenicity testing.
    Jiang H; Myler H; Zeng J; Mora J; Kolaitis G; Pillutla R
    Bioanalysis; 2019 Sep; 11(17):1605-1617. PubMed ID: 31208198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidation of the statistical factors that influence anti-drug antibody cut point setting through a multi-laboratory study.
    Nishimura K; Shibata H; Aoyama M; Hosogi J; Kadotsuji K; Minoura K; Mori T; Nakamura T; Nishimiya K; Nomura T; Saito T; Soma M; Wakabayashi H; Sakamoto N; Niimi S; Katori N; Saito Y; Ishii-Watabe A
    Bioanalysis; 2019 Mar; 11(6):509-524. PubMed ID: 30945932
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug interference in immunogenicity assays depends on valency.
    Rispens T; Hart MH; Ooijevaar-de Heer P; van Leeuwen A; Vennegoor A; Killestein J; Wolbink GJ; van der Kleij D
    J Pharm Biomed Anal; 2013 Nov; 85():179-85. PubMed ID: 23954437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics.
    Finco D; Baltrukonis D; Clements-Egan A; Delaria K; Gunn GR; Lowe J; Maia M; Wong T
    J Pharm Biomed Anal; 2011 Jan; 54(2):351-8. PubMed ID: 20863644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab.
    Gorovits B; Baltrukonis DJ; Bhattacharya I; Birchler MA; Finco D; Sikkema D; Vincent MS; Lula S; Marshall L; Hickling TP
    Clin Exp Immunol; 2018 Jun; 192(3):348-365. PubMed ID: 29431871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunoinhibition approach to overcome the impact of pre-existing antibodies on cut point establishment for immunogenicity assessment of moxetumomab pasudotox.
    Schneider AK; Vainshtein I; Roskos LK; Chavez C; Sun B; Liang M
    J Immunol Methods; 2016 Aug; 435():68-76. PubMed ID: 27220271
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Ito S; Ikuno T; Mishima M; Yano M; Hara T; Kuramochi T; Sampei Z; Wakabayashi T; Tabo M; Chiba S; Kubo C
    J Immunotoxicol; 2019 Dec; 16(1):125-132. PubMed ID: 31179789
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Ubah OC; Porter AJ; Barelle CJ
    J Immunol Res; 2020; 2020():7283239. PubMed ID: 32090129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges.
    van Brummelen EM; Ros W; Wolbink G; Beijnen JH; Schellens JH
    Oncologist; 2016 Oct; 21(10):1260-1268. PubMed ID: 27440064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity of the T Cell Response to Protein Biopharmaceuticals.
    Meunier S; de Bourayne M; Hamze M; Azam A; Correia E; Menier C; Maillère B
    Front Immunol; 2020; 11():1550. PubMed ID: 32793213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of TNF-Inhibitors.
    Atiqi S; Hooijberg F; Loeff FC; Rispens T; Wolbink GJ
    Front Immunol; 2020; 11():312. PubMed ID: 32174918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of drug specific circulating immune complexes from in vivo cynomolgus monkey serum samples.
    Pierog P; Krishna M; Yamniuk A; Chauhan A; DeSilva B
    J Immunol Methods; 2015 Jan; 416():124-36. PubMed ID: 25462536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A capillary electrophoresis based approach for the identification of anti-drug antibodies against camelid VHH biologics (Nanobodies®).
    Wiswell D; Neupane D; Chen M; Bowman EP; Linn D; Sawant A; Chackerian A; Zhang S; Escandón E
    J Pharmacol Toxicol Methods; 2020; 103():106872. PubMed ID: 32387500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity assay development and validation for biological therapy as exemplified by ustekinumab.
    Mojtahed Poor S; Ulshöfer T; Gabriel LA; Henke M; Köhm M; Behrens F; Geisslinger G; Parnham MJ; Burkhardt H; Schiffmann S
    Clin Exp Immunol; 2019 May; 196(2):259-275. PubMed ID: 30656642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioanalytical strategies in determining immunogenicity.
    Wadhwa M; Thorpe R
    Bioanalysis; 2019 Sep; 11(17):1535-1537. PubMed ID: 31697207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.